Vera Therapeutics (VERA) Current Assets (2020 - 2026)

Vera Therapeutics (VERA) has 7 years of Current Assets data on file, last reported at $615.8 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets rose 1.6% year-over-year to $615.8 million; the trailing twelve-month figure through Mar 2026 stood at $615.8 million (up 1.6% YoY), and the FY2025 full-year result was $728.9 million, up 11.93% from the prior year.
• Current Assets for Q1 2026 stood at $615.8 million, down from $728.9 million in the prior quarter.
• Across five years, Current Assets topped out at $728.9 million in Q4 2025 and bottomed at $125.0 million in Q3 2022.
• The 5-year median for Current Assets is $364.1 million (2024), against an average of $361.7 million.
• The widest annual swing landed in 2024, when Current Assets jumped 278.56%; it then gained 1.6% in 2026.
• A 5-year view of Current Assets shows it stood at $125.7 million in 2022, then soared by 36.85% to $172.0 million in 2023, then surged by 278.56% to $651.2 million in 2024, then rose by 11.93% to $728.9 million in 2025, then retreated by 15.51% to $615.8 million in 2026.
• The last three Current Assets figures came in at $615.8 million (Q1 2026), $728.9 million (Q4 2025), and $511.3 million (Q3 2025), per Business Quant data.

Peer Comparison